Showing items 301–400
Methods and compositions for selecting siRNA of improved functionality
Grant US-10233449-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-10233450-B2
United States of America
Compositions for modulating C9ORF72 expression
Grant US-10221414-B2
United States of America
Modulation of huntingtin expression
Grant US-10202603-B2
United States of America
Selective antisense compounds and uses thereof
Grant US-10202599-B2
United States of America
Oligonucleotide compositions with enhanced efficiency
Grant US-10196640-B1
United States of America
Aminoalcohol lipidoids and uses thereof
Grant US-10189802-B2
United States of America
Antibody to GDF8 and uses thereof
Grant US-10189896-B2
United States of America
SiRNA and their use in methods and compositions for inhibiting the expression of the…
Grant US-10167473-B2
United States of America
Mutants of cocaine esterase
Grant US-10160960-B2
United States of America
Aptamer methods and compositions
Grant US-10155940-B2
United States of America
Activation or reactivation of ache
Application US-10125117-B2
United States of America
Conjugated lipomers and uses thereof
Grant US-10117934-B2
United States of America
Double-stranded oligonucleotides
Grant US-10106793-B2
United States of America
Compositions and methods for controlling arthropod parasite and pest infestations
Grant US-10100306-B2
United States of America
Methods and compositions for plant pest control
Grant US-10077451-B2
United States of America
Soybean resistant to cyst nematodes
Grant US-10070614-B2
United States of America
SYSTEM AND METHOD FOR CELL TYPE-SPECIFIC TRANSLATION OF RNA MOLECULES IN EUKARYOTES
Application WO-2018149740-A1
World Intellectual Property Organisation (WIPO)
Isolated dsRNA molecules and methods of using same for silencing target molecules of…
Grant US-10041068-B2
United States of America
Method of treatment and agents useful for same
Grant US-10034920-B2
United States of America
Oligonucleotide compositions with enhanced efficiency
Grant US-10036025-B2
United States of America
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
Grant US-10017764-B2
United States of America
Methods and compositions for selecting siRNA of improved functionality
Grant US-10011836-B2
United States of America
Methods for modulating Ataxin 2 expression
Grant US-10006027-B2
United States of America
Methods and compositions for plant pest control
Grant US-10000767-B2
United States of America
Compositions and methods for modulating growth hormone receptor expression
Grant US-9994855-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-9988635-B2
United States of America
Polynucleotide molecules for gene regulation in plants
Grant US-9988634-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-9988630-B2
United States of America
Temporal regulation of gene expression by microRNAs
Grant US-9976152-B2
United States of America
Methods for modulating C9ORF72 expression
Grant US-9963699-B2
United States of America
Compositions and methods for modulating apolipoprotein (a) expression
Grant US-9957504-B2
United States of America
Compositions and methods for modulating HBV expression
Grant US-9932580-B2
United States of America
Compositions and methods for modulating apolipoprotein C-III expression
Grant US-9932581-B2
United States of America
Compositions and methods for modulation of SMN2 splicing in a subject
Grant US-9926559-B2
United States of America
Methods and compositions for increasing invertase activity in plants
Grant US-9920326-B1
United States of America
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
Grant US-9914922-B2
United States of America
Methods and compositions for treating neurological disease
Grant US-9914924-B2
United States of America
DOUBLE-STRANDED OLIGO RNA STRUCTURE COMPRISING MICRORNA
Application WO-2018038558-A1
World Intellectual Property Organisation (WIPO)
Method and medicament for inhibiting the expression of a given gene
Grant US-9902955-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of single and double…
Grant US-9879253-B2
United States of America
Methods and compositions for selecting siRNA of improved functionality
Grant US-9879266-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-9873875-B2
United States of America
Small conditional RNAs
Grant US-9856472-B2
United States of America
Compositions and methods for controlling Leptinotarsa
Grant US-9856495-B2
United States of America
Antibody to GDF8 and uses thereof
Grant US-9850301-B2
United States of America
Compositions and methods for controlling Leptinotarsa
Grant US-9850496-B2
United States of America
Methods and compositions for delaying senescence and improving disease tolerance and…
Grant US-9840715-B1
United States of America
Methods and compositions for selecting siRNA of improved functionality
Grant US-9839649-B2
United States of America
Polyamine-fatty acid derived lipidoids and uses thereof
Grant US-9840479-B2
United States of America
Biomolecular self-assembly
Grant US-9834439-B2
United States of America
Antisense compounds targeting genes associated with fibronectin
Grant US-9828602-B2
United States of America
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant US-9822365-B2
United States of America
Oligonucleotide compositions with enhanced efficiency
Grant US-9796978-B1
United States of America
Replication capable rAAV vectors encoding inhibitory siRNA and methods of their use
Grant US-9783805-B2
United States of America
Compositions and methods for controlling leptinotarsa
Grant US-9777288-B2
United States of America
Oligonucleotide compositions with enhanced efficiency
Grant US-9777275-B2
United States of America
Methods and compositions for selecting siRNA of improved functionality
Grant US-9777270-B2
United States of America
siRNA sequence-independent modification formats for reducing off-target phenotypic…
Grant US-9771583-B2
United States of America
RNAi targeting ZNF205
Grant US-9771586-B2
United States of America
Modified gene silencing
Grant US-9765351-B2
United States of America
MZB1, a novel B cell factor, and uses thereof
Grant US-9765134-B2
United States of America
Modulation of dystrophia myotonica-protein kinase (DMPK) expression
Grant US-9765338-B2
United States of America
AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
Application WO-2017151823-A1
World Intellectual Property Organisation (WIPO)
Modulation of TMPRSS6 expression
Grant US-9725722-B2
United States of America
Signal activatable constructs and related components compositions methods and systems
Grant US-9725715-B2
United States of America
Compositions and methods for modulation of SMN2 splicing in a subject
Grant US-9717750-B2
United States of America
RNAi targeting CNTD2
Grant US-9719092-B2
United States of America
RNAi targeting SEC61G
Grant US-9719094-B2
United States of America
Recombinant DNA constructs and methods for controlling gene expression
Grant US-9708620-B2
United States of America
Oligomeric compounds comprising bicyclic nucleosides and uses thereof
Grant US-9695418-B2
United States of America
Compositions for modulating Tau expression
Grant US-9683235-B2
United States of America
Modulation of hepatitis B virus (HBV) expression
Grant US-9677076-B2
United States of America
Modulation of prekallikrein (PKK) expression
Grant US-9670492-B2
United States of America
Modulation of alpha synuclein expression
Grant US-9663783-B2
United States of America
Modulators of itch ubiquitinase activity
Grant US-9658229-B2
United States of America
Methods for treating hypercholesterolemia
Grant US-9650636-B2
United States of America
Compositions and methods for modulating Tau expression
Grant US-9644207-B2
United States of America
Antibodies which bind to epithelial membrane protein 2 (EMP2)
Grant US-9624304-B2
United States of America
Modulation of UBE3A-ATS expression
Grant US-9617539-B2
United States of America
Compositions for modulating C9ORF72 expression
Grant US-9605263-B2
United States of America
Production of dentin, cementum and enamel by cells
Grant US-9597359-B2
United States of America
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LP…
Grant US-9593333-B2
United States of America
Double-stranded oligonucleotides
Grant US-9592250-B2
United States of America
Methods and compositions for modulating apolipoprotein (a) expression
Grant US-9574193-B2
United States of America
Antisense modulation of GCCR expression
Grant US-9567587-B2
United States of America
COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY
Application WO-2017024207-A1
World Intellectual Property Organisation (WIPO)
Aminoalcohol lipidoids and uses thereof
Grant US-9556110-B2
United States of America
Antisense compounds
Grant US-9550988-B2
United States of America
Compositions and methods for controlling arthropod parasite and pest infestations
Grant US-9540642-B2
United States of America
Method for opening tight junctions
Grant US-9540649-B2
United States of America
Invertebrate microRNAs
Grant US-9528121-B2
United States of America
Methods of treating kennedy's disease
Grant US-9523094-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-9518262-B2
United States of America
Modulation of enhancer RNA mediated gene expression
Grant US-9518261-B2
United States of America
Compositions and methods for inhibiting expression of the HAMP gene
Grant US-9506067-B2
United States of America
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND…
Application EP-3093351-A1
European Patent Office
siRNA-mediated gene silencing
Grant US-9487779-B2
United States of America
Antisense compounds targeting genes associated with fibronectin
Grant US-9487780-B2
United States of America
Showing items 301–400